Frequently Asked Questions
The COVID-19 pandemic has caused a decrease in the number of blood donations and transfusions, manufacturing and supply chain problems, and a decrease in visits to healthcare facilities, all of which have led to a decrease in the usage of these diagnostic products. This hampered market demand for these blood group typing products and services globally.
North America had the largest global blood group typing market revenue share in 2022.
The rise in the number of blood donations and transplantation procedures, as well as the increase in trauma and accident cases, are driving the growth of the global blood group typing market.
The PCR-based and microarray technique segment had the largest share in the global market.
In 2022, the blood banks segment had a major revenue share in the global market.